Lista de obras - Rosario López-Rodríguez

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.

artículo científico publicado en 2012

ATA homozigosity in the IL-10gene promoter is a risk factor for schizophrenia in Spanish females: a case control study ⬇️

artículo científico publicado el 9 de junio de 2011

Allele and genotype frequencies of serotonin and dopamine transporter and receptor polymorphisms in a Norwegian population

artículo científico publicado en 2011

Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link

artículo científico publicado en 2013

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.

artículo científico publicado en 2016

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

artículo científico publicado en 2016

DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome

artículo científico publicado en 2014

Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.

artículo científico publicado en 2017

Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers

Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers

artículo científico publicado en 2010

Evaluating a newly developed pharmacogenetic array: screening in a Spanish population.

artículo científico publicado en 2010

Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis

artículo científico publicado en 2018

Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers

artículo científico publicado en 2012

Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.

artículo científico publicado en 2011

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

artículo científico publicado en 2015

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

artículo científico publicado en 2016

Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers

artículo científico publicado en 2008

Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers

artículo científico publicado en 2009

Inhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activation

artículo científico publicado en 2014

Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C

artículo científico publicado en 2017

Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems.

artículo científico publicado en 2016

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C ⬇️

artículo científico publicado el 17 de agosto de 2011

Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers

artículo científico publicado en 2013

Pharmacogenetic relevance of the CYP2C9*3 allele in a tenoxicam bioequivalence study performed on Spaniards.

artículo científico publicado en 2008

Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects

artículo científico publicado en 2015

Polymorphisms in CYP2D6 have a greater effect on variability of risperidone pharmacokinetics than gender

article published in 2015

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy.

artículo científico publicado en 2013

Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects

artículo científico publicado en 2013

Preliminary evidence of sustained expression of angiopoietin-2 during monocyte differentiation in chronic hepatitis C.

artículo científico publicado en 2013

Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.

artículo científico publicado en 2018

SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations

artículo científico publicado en 2022

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.

artículo científico publicado en 2018

Lista de obras de Rosario López-Rodríguez

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping.

ATA homozigosity in the IL-10gene promoter is a risk factor for schizophrenia in Spanish females: a case control study ⬇️

Allele and genotype frequencies of serotonin and dopamine transporter and receptor polymorphisms in a Norwegian population

Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome

Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.

Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers

Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers

Evaluating a newly developed pharmacogenetic array: screening in a Spanish population.

Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis

Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers

Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers

Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers

Inhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activation

Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C

Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems.

Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C ⬇️

Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers

Pharmacogenetic relevance of the CYP2C9*3 allele in a tenoxicam bioequivalence study performed on Spaniards.

Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects

Polymorphisms in CYP2D6 have a greater effect on variability of risperidone pharmacokinetics than gender

Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy.

Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects

Preliminary evidence of sustained expression of angiopoietin-2 during monocyte differentiation in chronic hepatitis C.

Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.

SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations

Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.